πŸ‡ΊπŸ‡Έ FDA
Patent

US 9555099

Vaccines for HSV-2

granted A61KA61K2039/545A61K2039/55572

Quick answer

US patent 9555099 (Vaccines for HSV-2) held by IMMUNE DESIGN CORP. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/545, A61K2039/55572, A61K38/00, A61K39/12